21-Gene Oncotype DX® Recurrence-Score benefits and application in elderly breast cancer patients

被引：0
|
作者：
Chiru, E. D. [1 ]
Kuhar, C. Grasic [2 ]
Oseledchyk, A. [3 ]
Kurzeder, C. [3 ]
Vetter, M. [4 ]
机构：
[1] Cantonal Hosp Baselland, Internal Med, Liestal, Switzerland
[2] Inst Oncol Ljubljana, Oncol, Ljubljana, Slovenia
[3] Univ Hosp Basel, Oncol, Basel, Switzerland
[4] Cantonal Hosp Baselland, Oncol, Liestal, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11
引用
收藏
页码：43S / 43S
页数：1
相关论文
共 50 条
  • [31] Assessment of method of breast cancer detection and Oncotype DX recurrence score
    Kelly, Ciara Marie
    Parker, Imelda
    McCaffrey, John
    Crown, John
    O'Connor, Miriam
    McGee, Sharon F.
    Pusztai, Lajos
    Kelly, Catherine M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Budget impact analysis of the 21-gene assay (Oncotype DX® breast cancer) for the breast cancer treatment in the Basque country
    Toribio, M. G.
    Mar, J.
    Galve, E.
    Alvarez, I.
    Lahuerta, A.
    Unanue, G.
    Ibarrondo, O.
    Novas, P.
    Ancizar, N.
    Larburu, L.
    Hidalgo, M.
    Arango, J. F.
    Churruca, C.
    Plazaola, A.
    Perez, I.
    Purificacion Martinez del Prado, P.
    Dominguez, S.
    Paisan, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Impact of Oncotype DX Recurrence Score in the Management of Breast Cancer Cases
    Nguyen, Michaela T.
    Stessin, Alexander
    Nagar, Himanshu
    D'Alfonso, Timothy M.
    Chen, Zhengming
    Cigler, Tessa
    Hayes, Mary Kay
    Shin, Sandra J.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 182 - 190
  • [34] Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
    Joshua A. Bloom
    Yurie Sekigami
    Rebekah Young
    Lisa Macera
    Christy A. Russell
    Yu Cao
    Rachel J. Buchsbaum
    Stephen P. Naber
    Abhishek Chatterjee
    Annals of Surgical Oncology, 2021, 28 : 8711 - 8716
  • [35] Discordance in Oncotype DX Breast Recurrence Score Results for Bilateral Breast Cancer
    Bloom, J. A.
    Sekigami, Y.
    Cao, Y.
    Buchsbaum, R. J.
    Naber, S. P.
    Chatterjee, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S51 - S51
  • [36] Associations between the 21-gene Oncotype DX Recurrence Score (RS), Ki67, and Race in Early Breast Cancer (EBC) Using the National Cancer Database (NCDB)
    Patel, Rima
    Kwon, Deukwoo
    Van Hyfte, Grace
    Sparano, Joseph
    Tiersten, Amy
    CANCER RESEARCH, 2023, 83 (05)
  • [37] Correlation of Oncotype Dx Recurrence Score and Luminal Subtypes of Breast Cancer
    Henderson, S.
    Xie, X-J
    Peng, Y.
    Euhus, D.
    Leitch, M.
    Rao, R.
    Haley, B.
    Sarode, V.
    CANCER RESEARCH, 2010, 70
  • [38] Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients
    Petrakova, K.
    Petruzelka, L.
    Holanek, M.
    Svoboda, T.
    Benesova, V.
    Palacova, M.
    Kolarova, I.
    Bielcikova, Z.
    Chrapava, M.
    BREAST, 2019, 44 : S16 - S16
  • [39] A prognostic predictive model based on the correlation of standard clinicopathologic characteristics with oncotype Dx 21-gene recurrence score for node-negative and ER positive breast cancer
    Mankbadi, Michael R.
    Luo, Yi
    Yasin, Madiha
    Ben Khallouq, Bertha
    Moroose, Rebecca
    CANCER RESEARCH, 2018, 78 (04)
  • [40] Identifying Clinicopathological Factors Associated with Oncotype DX(R) 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada
    Gagnet, Simon
    Diorio, Caroline
    Provencher, Louise
    Mbuya-Bienge, Cynthia
    Lapointe, Julie
    Morin, Claudya
    Lemieux, Julie
    Nabi, Hermann
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
12345